Matches in SemOpenAlex for { <https://semopenalex.org/work/W1487752811> ?p ?o ?g. }
- W1487752811 endingPage "100" @default.
- W1487752811 startingPage "83" @default.
- W1487752811 abstract "Multiple myeloma (MM) is a severely debilitating, incurable, and uniformly fatal neoplastic disease of B cell origin (Barker et al., 1993). Although much effort has been directed at devising effective treatments for these patients, their prognosis and survival have been relatively unchanged over the last 30 years, except for a subgroup of patients undergoing successful autologous or allogeneic stem cell transplantation (Gahrton et al., 2001). The major source of morbidity and possible mortality associated with MM is osteolytic lesions throughout the axial skeleton (Coleman, 1997). Lytic bone lesions occur in over 70–80% of these patients (Anderson, 1999), and are frequently associated with severe bone pain and pathologic fractures. Up to one third of the patients develop hypercalcemia. The bone lesions result from increased osteoclastic bone resorption that occurs adjacent to the myeloma cells and not in areas of normal bone marrow (Anderson et al., 2002). These data suggest that locally acting factors produced by myeloma cells induce extensive bone destruction. Consistent with this hypothesis is the finding that cultures of human myeloma cells in vitro produce several osteoclast activating factors (OAFs), including TNF-α (Garret et al., 1987; Sati et al., 1999, IL-1-ß Lacy et al., 1999; Lust et al., 1999), and IL-6 (Bataille et al., 1995; Epstein et al., 1992; Iwasaki et al., 1999). However, none of these cytokines appears to be clearly responsible for the bone destruction in vivo. The increase in osteoclast (OCL) bone resorption in myeloma is usually associated with a marked impairment in osteoblast function Alexandrakis et al., 2002). Alkaline phosphatase activity in the serum is decreased or in the normal range, unlike patients with other types of osteolytic bone disease, and radionuclide scans do not show evidence of increased uptake in over 50% of patients with osteolytic lesions, indicating impaired osteoblast responses to the increase in bone resorption." @default.
- W1487752811 created "2016-06-24" @default.
- W1487752811 creator A5018507303 @default.
- W1487752811 creator A5048083753 @default.
- W1487752811 date "2004-01-01" @default.
- W1487752811 modified "2023-10-16" @default.
- W1487752811 title "MIP-1 Alpha and Myeloma Bone Disease" @default.
- W1487752811 cites W1525946619 @default.
- W1487752811 cites W1547160344 @default.
- W1487752811 cites W1595549379 @default.
- W1487752811 cites W1607308645 @default.
- W1487752811 cites W1632319713 @default.
- W1487752811 cites W1723444490 @default.
- W1487752811 cites W177092291 @default.
- W1487752811 cites W1902051780 @default.
- W1487752811 cites W1970792361 @default.
- W1487752811 cites W1977390830 @default.
- W1487752811 cites W1982915376 @default.
- W1487752811 cites W1999077925 @default.
- W1487752811 cites W2000937023 @default.
- W1487752811 cites W2019324879 @default.
- W1487752811 cites W2048560071 @default.
- W1487752811 cites W2052663369 @default.
- W1487752811 cites W2053508383 @default.
- W1487752811 cites W2058565853 @default.
- W1487752811 cites W2059873406 @default.
- W1487752811 cites W2064983485 @default.
- W1487752811 cites W2066000727 @default.
- W1487752811 cites W2066639236 @default.
- W1487752811 cites W2078493291 @default.
- W1487752811 cites W2079007861 @default.
- W1487752811 cites W2092974032 @default.
- W1487752811 cites W2099675490 @default.
- W1487752811 cites W2117963070 @default.
- W1487752811 cites W2119291835 @default.
- W1487752811 cites W2134828568 @default.
- W1487752811 cites W2140353133 @default.
- W1487752811 cites W2169802771 @default.
- W1487752811 cites W2180645505 @default.
- W1487752811 cites W2284769692 @default.
- W1487752811 cites W2289177026 @default.
- W1487752811 cites W2317397401 @default.
- W1487752811 cites W2341526758 @default.
- W1487752811 cites W30364595 @default.
- W1487752811 cites W4244239178 @default.
- W1487752811 cites W4251865761 @default.
- W1487752811 cites W4256655531 @default.
- W1487752811 cites W4321429654 @default.
- W1487752811 cites W94332232 @default.
- W1487752811 doi "https://doi.org/10.1007/978-1-4419-9129-4_4" @default.
- W1487752811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15043189" @default.
- W1487752811 hasPublicationYear "2004" @default.
- W1487752811 type Work @default.
- W1487752811 sameAs 1487752811 @default.
- W1487752811 citedByCount "37" @default.
- W1487752811 countsByYear W14877528112012 @default.
- W1487752811 countsByYear W14877528112013 @default.
- W1487752811 countsByYear W14877528112014 @default.
- W1487752811 countsByYear W14877528112017 @default.
- W1487752811 countsByYear W14877528112019 @default.
- W1487752811 countsByYear W14877528112021 @default.
- W1487752811 crossrefType "book-chapter" @default.
- W1487752811 hasAuthorship W1487752811A5018507303 @default.
- W1487752811 hasAuthorship W1487752811A5048083753 @default.
- W1487752811 hasConcept C126322002 @default.
- W1487752811 hasConcept C141071460 @default.
- W1487752811 hasConcept C142724271 @default.
- W1487752811 hasConcept C170493617 @default.
- W1487752811 hasConcept C202751555 @default.
- W1487752811 hasConcept C2776033226 @default.
- W1487752811 hasConcept C2776139714 @default.
- W1487752811 hasConcept C2776169692 @default.
- W1487752811 hasConcept C2776364478 @default.
- W1487752811 hasConcept C2776541429 @default.
- W1487752811 hasConcept C2778260815 @default.
- W1487752811 hasConcept C2780007613 @default.
- W1487752811 hasConcept C2781282405 @default.
- W1487752811 hasConcept C2911091166 @default.
- W1487752811 hasConcept C502942594 @default.
- W1487752811 hasConcept C55493867 @default.
- W1487752811 hasConcept C673006 @default.
- W1487752811 hasConcept C71924100 @default.
- W1487752811 hasConcept C86803240 @default.
- W1487752811 hasConceptScore W1487752811C126322002 @default.
- W1487752811 hasConceptScore W1487752811C141071460 @default.
- W1487752811 hasConceptScore W1487752811C142724271 @default.
- W1487752811 hasConceptScore W1487752811C170493617 @default.
- W1487752811 hasConceptScore W1487752811C202751555 @default.
- W1487752811 hasConceptScore W1487752811C2776033226 @default.
- W1487752811 hasConceptScore W1487752811C2776139714 @default.
- W1487752811 hasConceptScore W1487752811C2776169692 @default.
- W1487752811 hasConceptScore W1487752811C2776364478 @default.
- W1487752811 hasConceptScore W1487752811C2776541429 @default.
- W1487752811 hasConceptScore W1487752811C2778260815 @default.
- W1487752811 hasConceptScore W1487752811C2780007613 @default.
- W1487752811 hasConceptScore W1487752811C2781282405 @default.
- W1487752811 hasConceptScore W1487752811C2911091166 @default.
- W1487752811 hasConceptScore W1487752811C502942594 @default.